NCT06668948
The Prognostic Role of Fibrinogen to Albumin Ratio in Acute Leukemia Patients
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
The prognostic role of fibrinogen to albumin ratio in acute leukemia patients
Timeframe: 2025
Arms and interventions
patients with acute leukemia